Stay updated on Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    This change updates the ClinicalTrials.gov page’s displayed revision/version indicator from v3.5.0 to v3.5.3, reflecting a platform/content-system update rather than a modification to the NCT study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:54:50.000Z thumbnail image
  3. Check
    26 days ago
    No Change Detected
  4. Check
    47 days ago
    Change Detected
    Summary
    Version updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T05:01:31.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 was removed to reflect the latest page template. No study data or content related to the trial details, eligibility, or results was changed.
    Difference
    0.0%
    Check dated 2026-03-12T00:27:30.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding lapse notice plus Revision: v3.4.1; these updates are administrative and do not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:09:39.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Notice about government funding affecting site operations is shown. The page now lists Revision: v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:15:21.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The changes are cosmetic metadata updates (glossary toggle, Last Update Submitted that Met QC Criteria, No FEAR Act labeling, and Revision: v3.4.0) that do not affect core study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:09:04.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.